SCHEMBL67211

SCHEMBL67211

Cc1cccc(CO)c1[N+](=O)[O-]

nearest known ligand 0.64

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.64
ALDH1A1 P00352 2/20 0.64
TSHR P16473 3/20 0.56
HPGD P15428 3/20 0.46
POLB P06746 2/20 0.46
KAT2B Q92831 1/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
BMP1 P13497 1/20 0.43
HSD17B10 Q99714 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
PDCD1 Q15116 1/20 0.42
CD274 Q9NZQ7 1/20 0.42
MEN1 O00255 4/20 0.41
KMT2A Q03164 4/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
MAPT P10636 2/20 0.41
MAPK1 P28482 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31729335 1.00 TDP1 (0.64) TDP1ALDH1A1TSHRHPGDPOLB
SCHEMBL3818387 0.86 ALDH1A1 (0.46) TDP1ALDH1A1TSHRHPGD
SCHEMBL6108468 0.86 ALDH1A1 (0.60) TDP1ALDH1A1TSHRHPGDPOLB
SCHEMBL13344110 0.85 TDP1 (0.69) TDP1ALDH1A1TSHRHPGDPOLB
SCHEMBL18138442 0.83 TDP1 (0.67) TDP1ALDH1A1TSHRHPGDPOLB
SCHEMBL3781650 0.83 TDP1 (0.45) TDP1ALDH1A1TSHRPOLBSMN1; SMN2
SCHEMBL25234798 0.81 ALDH1A1 (0.48) TDP1ALDH1A1TSHRHPGDPOLB
SCHEMBL66337 0.81 TDP1 (0.64) TDP1ALDH1A1TSHRHPGDPOLB
SCHEMBL66829 0.81 ALDH1A1 (0.64) TDP1ALDH1A1TSHRHPGDPOLB
SCHEMBL16397238 0.81 TDP1 (0.58) TDP1ALDH1A1TSHRHPGDPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260028489-A1 SUPPORTED POLYMERIZATION INHIBITORS AND THEIR USE IN CURABLE COMPOSITIONS FOR 3D PRINTING ALIGN TECHNOLOGY INC (US) 2026-01-29 US claimed
CN-108482755-B Food package sealing machine 徐州工程学院 2020-08-25 CN claimed
CN-110835361-A Sialic acid glycosyl donor and preparation method and application thereof 山东大学 2020-02-25 CN claimed
US-20260028489-A1 SUPPORTED POLYMERIZATION INHIBITORS AND THEIR USE IN CURABLE COMPOSITIONS FOR 3D PRINTING ALIGN TECHNOLOGY INC (US) 2026-01-29 US disclosed
US-11458590-B2 Abrasive slurry regeneration method Konica Minolta, Inc. (JP) 2022-10-04 US disclosed
EP-3388195-B1 METHOD FOR REGENERATING ABRASIVE SLURRY KONICA MINOLTA INC (JP) 2022-05-04 EP disclosed
CN-108482755-B Food package sealing machine 徐州工程学院 2020-08-25 CN disclosed
CN-110835361-A Sialic acid glycosyl donor and preparation method and application thereof 山东大学 2020-02-25 CN disclosed
CN-108367410-B Method for rejuvenating slurry of abrasive material KONICA MINOLTA,INC. (JP) 2019-11-01 CN disclosed
US-10266725-B2 Method for preparing recycled abrasive slurry Konica Minolta, Inc. (JP) 2019-04-23 US disclosed
US-20180339399-A1 ABRASIVE SLURRY REGENERATION METHOD Konica Minolta, Inc. (JP) 2018-11-29 US disclosed
US-5719152-A Tricyclic quinoxalinedione derivatives SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 1998-02-17 US disclosed
US-5630872-A METAL ALKOXIDES, NITRO COMPOUNDS MITSUBISHI MATERIALS CORPORATION (JP) 1997-05-20 US disclosed
US-5614550-A ANTICHOLESTEROL AGENTS OR ARTERIOSCLEROSIS AGENTS FOR HUMANS SANKYO COMPANY, LIMITED (JP) 1997-03-25 US disclosed
US-5534529-A Substituted aromatic amides and ureas derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses SANKYO COMPANY, LIMITED (JP) 1996-07-09 US disclosed
EP-0632036-A2 Amide and urea derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses SANKYO COMPANY LIMITED (JP) 1995-01-04 EP disclosed
EP-0627434-A1 Tricyclic quinoxalinedione derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1994-12-07 EP disclosed
EP-0144695-B1 IMMUNOGENS, ANTIBODIES, LABELED CONJUGATES, AND RELATED DERIVATIVES FOR LIDOCAINE AND ANALOGS THEREOF MILES INC. (US) 1988-06-01 EP disclosed
US-4650771-A IMMONOASSAY MILES LABORATORIES, INC. (US) 1987-03-17 US disclosed
EP-0144695-A1 Immunogens, antibodies, labeled conjugates, and related derivatives for lidocaine and analogs thereof MILES INC. (US) 1985-06-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260028489-A1 SUPPORTED POLYMERIZATION INHIBITORS AND THEIR USE IN CURABLE COMPOSITIONS FOR 3D PRINTING ILK, MTCL3, MARK3 TDP1 4326/4885ALDH1A1 2419/4885TSHR 2217/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.